| 9962389 |
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group |
Ulrich Lücking, Rolf Bohlmann, Arne Scholz, Gerhard Siemeister, Mark Jean Gnoth +4 more |
2018-05-08 |
|
| 9669034 |
4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group |
Ulrich Lücking, Rolf Bohlmann, Arne Scholz, Gerhard Siemeister, Mark Jean Gnoth +4 more |
2017-06-06 |
|
| 9453051 |
Cyclosporin derivatives |
Gunter Fischer, Miroslav Malesevic, Frank Erdmann, Jan Kühling, Michael Bukrinsky +3 more |
2016-09-27 |
|
| 9242937 |
Pharmaceutically active disubstituted pyridine derivatives |
Peter Nussbaumer, Axel Choidas, Carsten Schulz-Fademrecht, Bert Klebl, Jan Eickhoff |
2016-01-26 |
|
| 9226929 |
Pharmaceutically active disubstituted triazine derivatives |
Uwe Koch, Peter Nussbaumer, Carsten Schulz-Fademrecht, Jan Eickhoff |
2016-01-05 |
|
| 9096608 |
Pharmaceutically active pyrazolo-triazine derivatives |
Jan Eickhoff, Gunther Zischinsky, Uwe Koch, Carsten Schultz-Fademrecht, Peter Nussbaumer |
2015-08-04 |
|
| 8916557 |
Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines |
Ulrich Lücking, Rolf Bohlmann, Arne Scholz, Gerhard Siemeister, Mark Jean Gnoth +4 more |
2014-12-23 |
|
| 6756403 |
Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor |
Barbara S. Briggs, James Kanter, John Mullins, Uko Effiong Udodong, Milton J. Zmijewski, Jr. +1 more |
2004-06-29 |
$389,809,000 |
| 6693109 |
Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
Matthew Joseph Fisher, Joseph A. Jakubowski, John Joseph Masters, Jeffrey Thomas Mullaney, Michael Paal +4 more |
2004-02-17 |
|
| 6528534 |
Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
Matthew Joseph Fisher, Joseph A. Jakubowski, John Joseph Masters, Jeffrey Thomas Mullaney, Kenneth J. Ruterbories +4 more |
2003-03-04 |
|
| 6448269 |
Glycoprotein IIb/IIIa antagonists |
Matthew Joseph Fisher, Anne Marie Happ, Joseph A. Jakubowski, Michael Dean Kinnick, Allen D. Kline +9 more |
2002-09-10 |
$109,326,000 |
| 6410562 |
Hypoglycemic imidazoline compounds |
Michael R. Jirousek, Michael Paal, Theo Schotten, Kumiko Takeuchi, Wolfgang Stenzel |
2002-06-25 |
$96,892,000 |
| 6291469 |
Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
Matthew Joseph Fisher, Joseph A. Jakubowski, John Joseph Masters, Jeffrey Thomas Mullaney, Kenneth J. Ruterbories +4 more |
2001-09-18 |
|
| 6020362 |
Glycoprotein IIB IIIA antagonists |
Matthew Joseph Fisher, Anne Marie Happ, Joseph A. Jakubowski, Michael Dean Kinnick, Allen D. Kline +9 more |
2000-02-01 |
$115,050,000 |
| 5731324 |
Glycoprotein IIb/IIIa antagonists |
Matthew Joseph Fisher, Anne Marie Happ, Joseph A. Jakubowski, Michael Dean Kinnick, Allen D. Kline +9 more |
1998-03-24 |
$70,695,000 |
| 5668152 |
Protein kinase C inhibitors |
William F. Heath, Jr., John H. McDonald, III, Theo Schotten |
1997-09-16 |
$188,455,000 |
